Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
Access to hospital-based eye care and reimbursement were policy topics at the…
Phase 2 data for kamuvudine K8, an investigational inflammasome-directed treatment from Inflammasome…
Two transactions announced in September and October 2026 show capital moving through…
GenSight Biologics and the Quinze-Vingts National Ophthalmology Hospital in Paris announced on…
Photo of Anat Loewenstein, MD, who served as the 2025 EURETINA president…
A new epidemiology study published in the British Journal of Ophthalmology reported…
A study of the effects of repetitive impacts to the head during…
Photo of Daniela Bacherini at the 2025 EURETINA meeting Daniela Bacherini, MD,…
As Ophthalmology Times celebrates its 50th anniversary, we took the opportunity to…
Photo of Boris Stanzel, MD, at the 2025 EURETINA meeting Professor Boris…
(Image credit: AdobeStock/phonlamaiphoto) Canadian researchers recently reported significant increases in complications during…
(Image Credit: AdobeStock) The US Food and Drug Administration (FDA) has approved…
(Image Credit: AdobeStock) The European Commission (EC) has granted marketing authorization for…
Enter your email address below and subscribe to our newsletter